BRIEF-IGM Biosciences Reduces Its Workforce By 73%
ReutersJan 9, 2025 6:04 PM
Jan 9 (Reuters) - IGM Biosciences Inc IGMS.O:
IGM BIOSCIENCES PROVIDES STRATEGIC UPDATE ON AUTOIMMUNITY PIPELINE PROGRAMS
IGM BIOSCIENCES INC -COMPANY REDUCING ITS WORKFORCE BY 73%
IGM BIOSCIENCES INC -COMPANY HALTING FURTHER DEVELOPMENT OF IMVOTAMAB (CD20 X CD3) AND IGM-2644 (CD38 X CD3)
IGM BIOSCIENCES INC - CURRENTLY EVALUATING INTERNAL OPTIONS AS WELL AS POTENTIAL STRATEGIC ALTERNATIVES
Source text: ID:nGNX7zNhzv
Further company coverage: IGMS.O
Disclaimer: For information purposes only. Past performance is not indicative of future results.
Related Articles
What Impact Will California Wildfires Have on The Stock Market?
TradingKey - Right now in the US, there are ferocious wildfires that are destroying acres of both land and homes in California. Being spread by strong winds, the fires are also heading towards major urban centres, like Los Angeles.TradingKey
Fri, Jan 10
Gold Stocks: Should Investors Consider Buying Them?
TradingKey - While global stock markets and Bitcoin are close to all-time highs, there are also other assets out there that investors should consider.TradingKey
Fri, Jan 10
Why Did Red-Hot Quantum Computing Stocks Just Plunge Over 40%?
TradingKey - Unless you’ve been living under a rock in the last few months of 2024, most investors will have been aware that quantum computing stocks were on fire. Given the hype surrounding the breakthrough of the “Willow” quantum computing chip by Alphabet Inc (NASDAQ: GOOGL), quantum computing stTradingKey
Fri, Jan 10
Why Did The S&P 500 And Nasdaq Composite Just Fall Over 1%?
TradingKey - The year 2025 started off on a pretty solid footing for investors with the key indices in the US – the S&P 500 Index and the tech-focused Nasdaq Composite Index – both posting gains in the first few days of trading. That followed on from some huge double-digit gains for 2023 and 2024.TradingKey
Wed, Jan 8
